BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2012

Nov 7, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2012-11-05

Reporting Person: BAFFI ROBERT (EVP, Technical Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-11-05	Common Stock	M	34230	$17.33	Acquired	134643	Direct
2012-11-05	Common Stock	S	20000	$46.00	Disposed	114643	Direct
2012-11-05	Common Stock	S	14230	$47.00	Disposed	100413	Direct
2012-11-05	Common Stock	M	25770	$17.54	Acquired	126183	Direct
2012-11-05	Common Stock	S	5770	$47.00	Disposed	120413	Direct
2012-11-05	Common Stock	S	20000	$49.00	Disposed	100413	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-11-05	Stock Option (right to buy)	$17.33	M	34230	Disposed	2017-06-06	Common Stock (34230)	Direct
2012-11-05	Stock Option (right to buy) Common Stock	$17.54	M	25770	Disposed	2016-11-19	Common Stock (25770)	Direct

Footnotes

F1: Transaction made pursuant to a Rule 10b5-1 plan executed on August 6, 2012.

F2: Options vest on November 7, 2007 and 1/48th on the 7th of each month thereafter.

F3: Options vest on May 20, 2007 and 1/48th on the 20th of each month thereafter.